FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

958611000001106: Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22592901000001116 Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
60126101000001115 Betamethasone valerate 0.1% / Neomycin 0.5% ointment 30 gram en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

6 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Is pack of Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Has active ingredient Neomycin sulfate false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Has active ingredient Betamethasone false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Has active ingredient Skin anti-infective false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Has active ingredient Neomycin false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Has active ingredient Betamethasone valerate false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Has VMP Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release cutaneous ointment true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Has specific active ingredient Betamethasone valerate true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Has specific active ingredient Neomycin sulfate true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Has dispensed dose form Ointment true Inferred relationship Existential restriction modifier
Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Has basis of strength substance Betamethasone true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (CST Pharma Ltd) 30 gram Is a True Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Inferred relationship Existential restriction modifier
Betnovate-N ointment (GlaxoSmithKline) 30 gram Is a True Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (Medihealth (Northern) Ltd) 30 gram Is a True Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (Essential Generics Ltd) 30 gram Is a True Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (Alliance Healthcare (Distribution) Ltd) 30 gram Is a True Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Inferred relationship Existential restriction modifier
Betamethasone valerate 0.1% / Neomycin 0.5% ointment (A A H Pharmaceuticals Ltd) 30 gram Is a True Neomycin 0.5% / Betamethasone valerate 0.1% ointment 30 gram Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start